---
id: EXP-2026-001
opportunity_id: OPP-2026-001
title: "Drift Aftercare Standard pilot"
status: completed_standardized
period_start: 2026-03-03
period_end: 2026-03-06
owner_job: JOB-CI-001
---

# Experiment Closeout: Drift Aftercare Standard pilot

## Outcome decision
- [ ] Scale
- [x] Standardize
- [ ] Rollback
- [ ] Retest

## Baseline vs observed
- Leading indicators:
  - Baseline: no mandatory post-change checkpoint rule enforced.
  - Target: checkpoint artifact created within 7 days and residual drift converted into explicit actions.
- Lagging indicators:
  - Baseline pending (track recurrence over next 2–6 weeks).
- Time-to-signal:
  - Expected first signal within 7 days.

## Safety and risk review
- Boundary exceptions: none expected (documentation/task process only).
- Incidents/regressions: none at activation.
- Rollback executed? (Y/N): N

## What we learned
- Aftercare checkpoints are effective when executed immediately after major structural changes; waiting for arbitrary dates created unnecessary latency.
- The aftercare pattern converted residual drift (`IMP-AUTO-20260303-03`) into concrete corrective execution and closure evidence within the same execution window.
- Reliability improved when checkpoint outputs were tied to validation gates (`tools/validate_repo.py --fix`) and committed as part of closure.

## Pilot runbook (execution plan)
1. Apply temporary aftercare rule to `IMP-AUTO-20260303-03`:
   - require one checkpoint artifact by 2026-03-10
   - include residual list, decomposition decisions, and explicit next actions
2. Log daily status note in `TASKS.md` sub-bullets under `OPS-2026-047`.
3. On day 7, close with one of: scale / standardize / rollback / retest.

## Retention updates (compounding rule)
- [x] Updated template(s)
- [x] Updated standard/process doc(s)
- [x] Updated automation/script(s)
- [x] Added/updated task(s)

## Evidence links
- `knowledge/opportunities/OPP-2026-001__drift-aftercare-standard.md`
- `knowledge/reports/WEEKLY_SYNTHESIS__2026-03-03.md`
- `metrics/CI_WEEKLY.md`
